RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Good Clinical Practice Compliance and the Start-up Company

Good Clinical Practice Compliance and the Start-up Company

Posted 01 May 2010 | By

Start-up drug or device companies tend to minimize spending and occasionally to be "penny wise and pound foolish." However, when conducting clinical studies, rules must be followed to ensure the reliability of data. There are many pitfalls a start-up can fall into when first conducting clinical studies. These can be minimized or eliminated by planning the various items for a clinical study before execution and employing skilled and experienced individuals to monitor and audit the studies.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.